Fighting for First Breath: ISSAD 2026 Tackles GBS Disease in Africa
By Wilson Amondo The 2026 International Symposium on Streptococcus and GBS Disease (ISSAD) is set to kick off in East Africa, bringing together top experts to tackle the pressing issue of Group B Streptococcus (GBS) disease. This year's conference is particularly significant, as it coincides with a surge in GBS cases in sub-Saharan Africa. As the opening panel takes the stage, discussions will center around the latest vaccine candidates in clinical trials, with a focus on maternal immunisation approaches that could protect both mothers and newborns. The plenary session on disease burden and surveillance will reveal updated global estimates, highlighting the daunting data gaps in Africa and South Asia. But it's not just about numbers – the conference will delve into the human impact of GBS disease, with stories of stillbirths, prematurity, and maternal mortality. The Child Health and Mortality Prevention Surveillance (CHAMPS) network will share recent data, shedding ...